| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in ADAG over the last quarter tilts toward buying: insiders added a net 47,535 shares worth roughly $162K. In the past 30 days, 1 insider bought and 0 sold. The tilt toward buying has held up recently.
The largest recent buyer is Tam Man Kin (Chief Financial Officer), now holding an estimated $36K in ADAG. Open-market purchases by a top executive tend to carry more weight than sales, which are often driven by diversification or scheduled 10b5-1 plans.
Classified under Biotechnology (Healthcare sector), ADAG's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 90.0K | - | - | |
| Dir | 90.0K | - | - | |
| CEO | 88.5K | $279.2K | - | |
| Dir | 85.0K | - | - | |
| CFO | 12.0K | $36.0K | +2.0K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Tam Man Kin | Chief Financial Officer | Buy | 2,000 | $3.00 | $6,000.00 | +20.0% | |
| Sep 16, 2026 | Luo Peter | Chief Executive Officer | Buy | 20,290 | $3.15 | $63,980.46 | +29.7% | |
| Aug 14, 2026 | Do Cuong V | Director | Buy | 2,000 | $3.75 | $7,500.00 | New | |
| Aug 5, 2026 | Luo Peter | Chief Executive Officer | Buy | 23,245 | $3.65 | $84,763.87 | +51.7% |